Charles Wilcox
Executive Director
Pharmacology Research Institute

A member of the PRI team since 1978, and having been involved in more than 850 studies, Dr. Wilcox is experienced in all phases [I-IV] of clinical research. His responsibilities include the overall conduct (and sometimes design) of clinical investigations performed at the Institute. Operational duties include planning, staffing, budgeting, patient recruitment, fulfillment of and compliance with U.S. and foreign regulatory requirements, as well as the dissemination (i.e. publication and presentation) of research results. Clinical responsibilities include preliminary pre-screening of study participants, global ratings (i.e. ADAS-Cog., CGIC, CDR and CIBIC-Plus, etc.), medication accountability and assistance with informed consent processes.